ORMP
Price
$4.48
Change
-$0.00 (-0.00%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
197.59M
45 days until earnings call
Intraday BUY SELL Signals
PULM
Price
$1.57
Change
+$0.03 (+1.95%)
Updated
Oct 2, 04:58 PM (EDT)
Capitalization
5.81M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ORMP vs PULM

ORMP vs PULM Comparison Chart in %
View a ticker or compare two or three
VS
ORMP vs. PULM commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a StrongBuy and PULM is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ORMP vs PULM: Fundamental Ratings
ORMP
PULM
OUTLOOK RATING
1..100
7694
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1599
PRICE GROWTH RATING
1..100
3960
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for PULM (81) in the Biotechnology industry. This means that ORMP’s stock grew significantly faster than PULM’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as PULM (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to PULM’s over the last 12 months.

ORMP's SMR Rating (15) in the Pharmaceuticals Other industry is significantly better than the same rating for PULM (99) in the Biotechnology industry. This means that ORMP’s stock grew significantly faster than PULM’s over the last 12 months.

ORMP's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as PULM (60) in the Biotechnology industry. This means that ORMP’s stock grew similarly to PULM’s over the last 12 months.

ORMP's P/E Growth Rating (91) in the Pharmaceuticals Other industry is in the same range as PULM (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to PULM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPPULM
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 11 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (ORMP: $4.48 vs. PULM: $1.54)
Brand notoriety: ORMP and PULM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 151% vs. PULM: 42%
Market capitalization -- ORMP: $197.59M vs. PULM: $5.81M
ORMP [@Biotechnology] is valued at $197.59M. PULM’s [@Biotechnology] market capitalization is $5.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 2 FA rating(s) are green while PULM’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 2 green, 3 red.
  • PULM’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than PULM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 4 TA indicator(s) are bullish while PULM’s TA Score has 4 bullish TA indicator(s).

  • ORMP’s TA Score: 4 bullish, 5 bearish.
  • PULM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than PULM.

Price Growth

ORMP (@Biotechnology) experienced а -6.47% price change this week, while PULM (@Biotechnology) price change was -7.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.68%. For the same industry, the average monthly price growth was -14.47%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

ORMP is expected to report earnings on Nov 16, 2026.

PULM is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ORMP
Daily Signal:
Gain/Loss:
PULM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBUS1.630.02
+1.24%
Cibus
ASH68.610.69
+1.02%
Ashland
VTRS17.46-0.26
-1.47%
Viatris
SUPV6.82-0.29
-4.08%
Grupo Supervielle SA
KAPA1.56-0.08
-4.88%
Kairos Pharma Ltd

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with DRTS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then DRTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-4.07%
DRTS - ORMP
50%
Loosely correlated
-2.68%
INO - ORMP
44%
Loosely correlated
-0.82%
MBIO - ORMP
44%
Loosely correlated
+0.97%
CGEM - ORMP
42%
Loosely correlated
-5.34%
CGEN - ORMP
41%
Loosely correlated
-1.68%
More

PULM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PULM has been loosely correlated with ORMP. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PULM jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
+1.32%
ORMP - PULM
33%
Loosely correlated
-4.07%
INM - PULM
30%
Poorly correlated
-0.74%
AARD - PULM
30%
Poorly correlated
N/A
ALT - PULM
29%
Poorly correlated
-3.50%
GERN - PULM
27%
Poorly correlated
-1.63%
More